Vigilant Biosciences Launches Clinical Studies of Oral Cancer Assay

2017-05-12

Vigilant Biosciences has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative assay in support of its registration submission to the Food and

Save Lives With Simple Oral Cancer Screenings

2016-10-17

According to the World Health Organization, there are more than 529,000 new cases of oral (lip, oral cavity, and pharynx) cancer each year worldwide, with

Oral Cancer Test Gets European Conformity (CE) Mark

2016-05-06

Vigilant Biosciences has received the European Conformity (CE) mark for its OncAlert Oral Cancer RAPID Test, enabling the company to market the product in the